Literature DB >> 165514

RNA of replication-defective strains of Rous sarcoma virus.

P H Duesberg, S Kawai, L H Wang, P K Vogt, H M Murphy, H Hanafusa.   

Abstract

The RNA of a replication-defective (rd) mutant, isolated from stocks of nondefective (nd) Schmidt-Ruppin Rous sarcoma virus of subgroup A (SR-A) and termed SR-N8, was compared to the RNAs of SR-A, of a transformation-defective derivative of SR-A (td SR-A) and of rd Bryan Rous sarcoma virus, RSV (minus). The molecular mass of the 30-40S species of SR-N8 RNA was estimated to be 21% (congruent to 7.5 to 8 times 10-5 daltons) smaller than that of SR-A by (i) electrophoresis in polyacrylamide gels and (ii) analyses of RNA complexity based on RNase T1-resistant oligonucleotides. ST-N8 shares probably all (=14) of its large RNase T1-resistant oligonucleotides with the RNA of SR-A as judged from the chromatographic distribution and the RNase A-resistant fragments obtained from RNase T1-resistant oligonucleotides. However, SR-N8 RNA lacked six large oligonucleotides which were present in the RNAs of SR-A and td SR-A. Conversely, the RNAs of SR-A, and of SR-N8 contained two oligonucleotides not found in td SR-A. The RNA of SR-N8 was found to differ from that of RSV (minus) in its electrophoretic mobility and its fingerprint pattern. It is concluded that the RNA of SR-N8 was generated by a deletion of SR-A. The extent of this deletion is compatible with the notion that the genetic information for the large viral envelope glycoprotein (molecular mass = 70,000-85,000 daltons) has been lost from the RNA of SR-A to yield SR-N8 RNA. From a comparison of td and rd deletion mutants, it appears that loss of different functions corresponds to the absence of different oligonucleotides in their RNA.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 165514      PMCID: PMC432579          DOI: 10.1073/pnas.72.4.1569

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Electrophoretic analysis of the RNA of avian tumor viruses.

Authors:  C M Scheele; H Hanafusa
Journal:  Virology       Date:  1972-12       Impact factor: 3.616

2.  Existence and expression of tumor virus genes in chick embryo cells.

Authors:  T Hanafusa; H Hanafusa; T Miyamoto; E Fleissner
Journal:  Virology       Date:  1972-02       Impact factor: 3.616

3.  The a subunit in the RNA of transforming avian tumor viruses. I. Occurrence in different virus strains. II. Spontaneous loss resulting in nontransforming variants.

Authors:  G S Martin; P H Duesberg
Journal:  Virology       Date:  1972-02       Impact factor: 3.616

4.  Genetic recombination with avian tumor virus.

Authors:  S Kawai; H Hanafusa
Journal:  Virology       Date:  1972-07       Impact factor: 3.616

5.  Spontaneous segregation of nontransforming viruses from cloned sarcoma viruses.

Authors:  P K Vogt
Journal:  Virology       Date:  1971-12       Impact factor: 3.616

6.  Isolation of different kinds of non-virus producing chick cells transformed by Schmidt-Ruppin strain (subgroup A) of Rous sarcoma virus.

Authors:  S Kawai; T Yamamoto
Journal:  Jpn J Exp Med       Date:  1970-08

7.  Glycoprotein components of avian and murine RNA tumor viruses.

Authors:  P H Duesberg; G S Martin; P K Vogt
Journal:  Virology       Date:  1970-08       Impact factor: 3.616

8.  A type of chick embryo cell that fails to support formation of infectious RSV.

Authors:  T Hanafusa; T Miyamoto; H Hanafusa
Journal:  Virology       Date:  1970-01       Impact factor: 3.616

9.  Evidence for crossing-over between avian tumor viruses based on analysis of viral RNAs.

Authors:  K Beemon; P Duesberg; P Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  1974-10       Impact factor: 11.205

10.  Properties and location of poly(A) in Rous sarcoma virus RNA.

Authors:  L H Wang; P Duesberg
Journal:  J Virol       Date:  1974-12       Impact factor: 5.103

View more
  28 in total

1.  Viral glycoprotein synthesis studies in an established line of Japanese quail embryo cells infected with the Bryan high-titer strain of Rous sarcoma virus.

Authors:  M S Halpern; D P Bolognesi; R R Friis
Journal:  J Virol       Date:  1976-05       Impact factor: 5.103

2.  Polymerase-defective mutant of the Bryan high-titer strain of Rous sarcoma virus.

Authors:  M Sudol; T L Lerner; H Hanafusa
Journal:  Nucleic Acids Res       Date:  1986-03-11       Impact factor: 16.971

Review 3.  The early history of tumor virology: Rous, RIF, and RAV.

Authors:  Harry Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-03       Impact factor: 11.205

4.  Cell-free translation of virion RNA from nondefective and transformation-defective Rous sarcoma viruses.

Authors:  T Pawson; G S Martin; A E Smith
Journal:  J Virol       Date:  1976-09       Impact factor: 5.103

5.  Transformation-defective mutants of Rous sarcoma virus with src gene deletions of varying length.

Authors:  S Kawai; P H Duesberg; H Hanafusa
Journal:  J Virol       Date:  1977-12       Impact factor: 5.103

6.  Partial nucleotide sequence of Rous sarcoma virus-29 provides evidence that the original Rous sarcoma virus was replication defective.

Authors:  A Dutta; L H Wang; T Hanafusa; H Hanafusa
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

7.  Cellular sequences are present in the presumptive avian myeloblastosis virus genome.

Authors:  L M Souza; J N Strommer; R L Hillyard; M C Komaromy; M A Baluda
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

8.  Evidence for the common origin of viral and cellular sequences involved in sarcomagenic transformation.

Authors:  L H Wang; P Snyder; T Hanafusa; H Hanafusa
Journal:  J Virol       Date:  1980-07       Impact factor: 5.103

9.  Complementation rescue of Rous sarcoma virus from transformed mammalian cells by polyethylene glycol-mediated cell fusion.

Authors:  K S Steimer; D Boettiger
Journal:  J Virol       Date:  1977-07       Impact factor: 5.103

10.  Type C viral gag gene expression in chicken embryo fibroblasts and avian sarcoma virus-transformed mammalian cells.

Authors:  F H Reynolds; C A Hanson; S A Aaronson; J R Stephenson
Journal:  J Virol       Date:  1977-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.